The value of follow‐up FDG‐PET/CT in the management and prognosis of patients with HPV‐positive oropharyngeal squamous cell carcinoma
Open Access
- 7 September 2015
- journal article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 59 (6) , 681-686
Abstract
Introduction: To establish the accuracy of follow‐up fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT and the impact of FDG PET/CT result on management decisions and patient outcome prediction (overall and progression free survival) in human papilloma virus (HPV)‐positive oropharyngeal squamous cell carcinoma (SCC).Patients and Methods: We included 96 HPV‐positive oropharyngeal SCC (OPSCC) patients with 254 follow‐up PET/CT scans in the study. The PET/CT result accuracy was established with histopathology or 6‐month clinical follow‐up as reference standard. The impact on change in management was established for each follow‐up PET/CT scan. Overall survival was evaluated using Kaplan–Meier plots with a Log‐rank test.Results: The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the follow‐up FDG‐PET/CT were 97.0%, 92.5%, 67.0%, 99.5% and 93.1%, respectively. Follow‐up PET/CT results were helpful in excluding tumour in 22% (9/41) of scans performed with prior clinical suspicion of disease and identified potential disease in 9.9% (21/213) scans performed without prior clinical suspicion. There was a change in management after 12.6% (32/254) scans. In 84.3% (214/254) scans, the patients were either observed or the same treatment was continued. The overall survival differed significantly between patients with a negative versus positive follow‐up scan (log rank P < 0.001). The median progression free survival was 28 months, if the first follow‐up scan performed within 6–12 months post‐treatment completion was negative.Conclusion: Follow‐up FDG PET/CT scans have an impact on the management plan and add value to clinical assessment in patients with HPV‐positive OPSCC.Keywords
This publication has 20 references indexed in Scilit:
- Predictive accuracy of first post‐treatment PET/CT in HPV‐related oropharyngeal squamous cell carcinomaThe Laryngoscope, 2014
- Improved Survival with HPV among African Americans with Oropharyngeal CancerClinical Cancer Research, 2013
- Rates and Determinants of Oral Human Papillomavirus Infection in Young MenSexually Transmitted Diseases, 2012
- Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should knowEuropean Archives of Oto-Rhino-Laryngology, 2012
- Prevalence of Oral HPV Infection in the United States, 2009-2010JAMA, 2012
- Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyAnnals of Oncology, 2011
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Human papilloma virus: A new risk factor in a subset of head and neck cancersJournal of Cancer Research and Therapeutics, 2011
- Population-based analysis of oral and oropharyngeal carcinoma: Changing trends of histopathologic differentiation, survival and patient demographicsThe Laryngoscope, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010